June 18, 2024 June 18, 2024Categories News StoriesDr. Barbara Burtness and colleagues highlight progress in head and neck cancer MRD at ASCO, but caution that results remain preliminary (free registration is required to view this article)
June 14, 2024 June 14, 2024Categories News StoriesE1910 trial leads to an FDA approval in B-cell acute lymphoblastic leukemia (B-ALL)
June 13, 2024 June 13, 2024Categories News StoriesNivolumab fails to benefit esophageal cancer treatment in the EA2174 trial: Dr. Jennifer Eads
June 13, 2024 June 13, 2024Categories News StoriesDr. Jennifer Eads on nivolumab plus neoadjuvant chemoradiation in esophageal/GEJ cancer (trial EA2174)
June 13, 2024 June 13, 2024Categories News StoriesPersonalizing chemotherapy for Black women in study EAZ171 (story by the Susan G. Komen organization)
June 13, 2024 June 13, 2024Categories News StoriesEAZ171 trial suggests Black patients with breast cancer have lower risk of taxane-induced peripheral neuropathy with docetaxel than paclitaxel
June 13, 2024 June 13, 2024Categories News StoriesStudy EAZ171 suggests docetaxel is superior for neuropathy in Black patients with breast cancer
June 13, 2024 June 13, 2024Categories AnnouncementsThe June 2024 News from ECOG-ACRIN blog is now available
June 3, 2024 June 3, 2024Categories Press ReleasesPress Release: ECOG-ACRIN completes first trial of Black patients with early-stage breast cancer
